Cargando…
SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoma, is a heterogeneous disease where the outcome for patients with early relapse or refractory disease is very poor, even in the era of immunochemotherapy. In order to describe possible differences in global protein expression and network...
Autores principales: | Rüetschi, Ulla, Stenson, Martin, Hasselblom, Sverker, Nilsson-Ehle, Herman, Hansson, Ulrika, Fagman, Henrik, Andersson, Per-Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427854/ https://www.ncbi.nlm.nih.gov/pubmed/26060582 http://dx.doi.org/10.1155/2015/841769 |
Ejemplares similares
-
Age is the most important predictor of survival in diffuse large B‐cell lymphoma patients achieving event‐free survival at 24 months: a Swedish population‐based study
por: Abu Sabaa, Amal, et al.
Publicado: (2021) -
Comparing SILAC- and Stable
Isotope Dimethyl-Labeling
Approaches for Quantitative Proteomics
por: Lau, Ho-Tak, et al.
Publicado: (2014) -
A SILAC-Based Method for Quantitative Proteomic Analysis of Intestinal Organoids
por: Gonneaud, Alexis, et al.
Publicado: (2016) -
Initial Quantitative Proteomic Map of 28 Mouse Tissues Using the SILAC Mouse
por: Geiger, Tamar, et al.
Publicado: (2013) -
Quantitative proteome analysis of Merkel cell carcinoma cell lines using SILAC
por: Kotowski, Ulana, et al.
Publicado: (2019)